-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Multi-arm clinical trials with treatment selection: what can be gained and at what price?
Thomas Jaki
Clinical Trail Methodology: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation 2014 4:9, 847-865.
Corrigendum: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Overcoming resistance in chronic myeloid leukemia
Rupali Roy & Moshe Talpaz
Commentary: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fesoterodine fumarate for the treatment of overactive bladder in the elderly- a review of the latest clinical data
Adrian Wagg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation